Payer perspectives on outcomes tracking for value-based payment arrangements (VBPs)
With the new CMS rule changing Medicaid Best Price reporting to encourage VBPs, many options are available for which healthcare system players will collect, protect and adjudicate the outcomes data required by VBP participants.
PAYING FOR CURES
Self-Insured Employers Workshop in June
Explore the impact of cell and gene therapies on your health benefit plans, survey the risks, and learn about solutions.
IN THE COMMUNITY
Mark Trusheim spoke at the 2nd Annual Gene Therapy for Blood Disorders meeting on March 11, in a session called, “Evaluating Different Payment Models for Different Blood Indications.”
FoCUS research was cited in the article “Cell and gene therapy: Overview, Current Landscape and Future Trends”.
On April 12 Mark Trusheim will lead a workshop for ISPOR, entitled “Adaptive Reimbursement: Innovating for Patient Access and Better Outcomes for All”, including Angela Banks Vice President, External Affairs, UnitedHealth Group; Ron Potts, MD; Medical Director Quality Improvement Kaiser Permanente, Chief Medical Officer, INTERLINK; and David Strutton, PhD, VP, Global Pharmaceuticals & Policy Research, Center for Observational and Real-World Evidence, Merck & Co.
Tsega Meshesha, MS joins as Program Manager
Ms Meshesha is a public health research professional who designs evidence-based solutions that improve health outcomes both domestically and internationally. Learn more about Tsega
SAVE THE DATES
FoCUS 2021 Design Labs
April 27–28 and October 12–14 (TBC). By invitation only.